Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
yup 100% you nailed it.
Golden science in the hands of self-dealing inadequate management
100% agree
that I agree with you on
if NWBO SP gets to $20 in the week after TLD I will donate $100,000 to a charity of your choosing.
But Advent does not own anything they are building
Hope you’re selling soon! Meaning, TLD!!
no Im not selling now.
Im selling after TLD the science is solid thanks to LL and Bosch, no thanks to LP and LG.
But thanks for the advice
yeh I know the Woodford narrative I wasnt there I cant tell if that is what happened yes or no. Maybe it happened maybe it didn't. When it comes to NWBO I only believe what can be proven or what the company officially has stated. not what the narrative is here
certainly not LP
The fact that there are not institutional investors is because it is an OTC Penny stock
After Woodford takes a bath on NW Bio, British investor decides to towel off
lol you have a way with words PM. If all turns out bad, then there is no reason why you could not be a professional writer.
Its actually more a whack a mole game here
The moment we say NWBO should share in the return of investment for Advent its we should not want NWBO to be a CDMO NWBO should focus. If we then say ok NWBO should not have invested in CDMO facility + equipment but have this arranged with a third party its NWBO needs to be a CDMO for the production of L so it can focus.
If we then say where is evidence that Advent will share in the revenue of Advent then it is the certification is not even in. If we say the certification is in name of Advent, not NWBO then it's the property that will get certified it only happens to be so that Advent's name is on the certificate. Hahahahah lol again no Advent does not receive the certificate only its name is on the paper, seriously. LP has cast some spell over some people they do her bidding so well.
Everyone would agree that NWBO’s management is terribly conflicted and that the fund manager (and Chief Executive for both entities) is leveraging one portfolio company that it controls to establish a second portfolio company that it wholly owns. Every other explanation would simply be rejected as self serving.
You are right your post makes absolutely no sense
And you make money if any of those companies do cell production at Sawston.
Fact 1. NWBO sold Sawston and pays to lease the space that Advent occupies
Fact 2. The CEO for NWBO is also the chief executive for Advent
Fact 3. Toucan owns Advent
Fact 4. NWBO has no ownership interest in Advent
Fact 5. Advent receives the profits from those contracts, not NWBO
Fact 6. NWBO receives no profits from Advent, even if Advent were sold, despite funding the purchase of those assets and startup costs
Tell me where those facts are not facts.
It would be a huge waste if very costly capital and a huge distraction for this tiny company to go into that business or to fund it
come on jack whats a few hundred million as an ROI on $1.35 among friends lol
exactly its probably "only" a couple of hundred of millions that NWBO shareholders will be missing out on if and when Advent will be sold but its again a matter of trust and this:
but it really gets to the fiduciary responsibilities of management.
yes the ultimo date is 31-12
also interesting
https://www.dropbox.com/s/ibsdhvxxyl883p6/companies_house_document.pdf?dl=0
25 Nov 2020 Confirmation statement made on 3 October 2020 with updates
On Nov 25 2020 the only share in Advent moved from Toucan Capital fund LP to Toucan Holdings LLC.
Someone did not want to be caught with their hand in the cookie jar ;) lol
Absolutely
https://www.dropbox.com/s/ylmqkcku2jyjj7m/advent%202019.pdf?dl=0
Total exemption full accounts made up to 31 December 2019 Advent
Can you post the paid up share capital page?
its probably redundant if I say
A. Incredible well summarized and well said
B. 100% agree :)
Had NWBO established a subsidiary to manufacture the vaccine to include on its balance sheet the cap ex to build out the facility and accounted for all the startup costs — all funded by NWB0 shareholders — and then hired Advent to just provide employee services under a service contract, that would be the typical business relationship
I have been trained to always think critically and find it unhealthy to worship NWBO management as if they were half Gods. Its good to hear you have that same train of thought.
What is the end result of this for you?
Both sides have spoken, the arguments are now circular. What is your play?
Im long in Northwest. Im absolutely conviced their IP will be worth over 22 billion after being approved. Im also convinced they will be approved, data is great all that. I have not said anything bad about NWBO. If I have please point me where I have.
I am however not long in Advent or any other private holdings from LP.
Also Im not pleased that LP is financing Advent again and building a CDMO/GMP for herself with the help of NWBO funds. I dont see any benefit for NWBO in the ways she is financing Advent.
Since it has become obvious that Advent has been granted the license to operate Swaston as a CDMO/GMP it has been obvious what they are doing. That has nothing to do with NWBO.
There is nothing nefarious about Biogen making antibodies for J&J. It makes business sense for J&J to hire Biogen to do the grunt work while they reap the majority of the profits. Plain and simple business transaction. If J&J wants to pull out and have Genetech manufacture instead, that option is available to them…
Advent Bioservices began activity as a cell therapy contract development & manufacturing organization in 2016 and is in the process of building a state-of-the-art multiproduct GMP production facility outside Sawston in Cambridgeshire, which will allow the scale up of current commercial production and the provision of contract manufacturing services to meet the growing demand for such services in the UK.
Methods, Results & Conclusion
The Sawston facility is located just 7 miles outside Cambridge city centre with excellent transport links to Central London, London Stansted airport and is 4 miles from the M11 motorway. The facility consists of 1700m2 of GMP lab space, 325m2 for process development and an additional 1450 m2 for future expansion. Initial construction work has focused on the building of 2 separate GMP suites with grade B/C classified areas, in house QC testing and office space as well as a multipurpose cryogenic storage unit.
The entire facility will operate under a comprehensive IT infrastructure including eQMS and an eBMR, with a LIMS with secure storage for client documents and paperless systems. ClientS operating within these suites <Sawston thus> will benefit from already validated cleanrooms, in-house environmental monitoring system as well as training, ancillary services and technical support inclusive of process development and validation. Our cryogenic facilities are available to external clientS as off-site storage and offer disaster recovery services as per UK regulatory (HTA) requirements.
Advent Bioservices is currently in the process of applying for licencing and accreditation from UK authorities including the HTA, MHRA and HFEA for the Sawston site.
Additionally I recently proposed somewhat facetiously that Advent could man the lines at CRL/Cognate…..perhaps there could be credence in this?
At preset does Advent have possession (own) any NWBO ready infrastructure?
No long term liabilities are listed so everything is contained in creditors all due within one year…..
This is not what I think the meaning of “We are going it alone” statement from Mgt several years ago actually meant. Unless Linda speaks as per Queen Elizabeth….
exactly this is another Cognate in the making ready to be sold really good for LP and LG but not for NWBO shareholders but financed by them. I did not see any lease income from the Sawston facility and for the equipment. have you?
Advent Bioservices began activity as a cell therapy contract development & manufacturing organization in 2016 and is in the process of building a state-of-the-art multiproduct GMP production facility outside Sawston in Cambridgeshire, which will allow the scale up of current commercial production and the provision of contract manufacturing services to meet the growing demand for such services in the UK.
Methods, Results & Conclusion
The Sawston facility is located just 7 miles outside Cambridge city centre with excellent transport links to Central London, London Stansted airport and is 4 miles from the M11 motorway. The facility consists of 1700m2 of GMP lab space, 325m2 for process development and an additional 1450 m2 for future expansion. Initial construction work has focused on the building of 2 separate GMP suites with grade B/C classified areas, in house QC testing and office space as well as a multipurpose cryogenic storage unit.
The entire facility will operate under a comprehensive IT infrastructure including eQMS and an eBMR, with a LIMS with secure storage for client documents and paperless systems. ClientS operating within these suites will benefit from already validated cleanrooms, in-house environmental monitoring system as well as training, ancillary services and technical support inclusive of process development and validation. Our cryogenic facilities are available to external clients as off-site storage and offer disaster recovery services as per UK regulatory (HTA) requirements.
Advent Bioservices is currently in the process of applying for licencing and accreditation from UK authorities including the HTA, MHRA and HFEA for the Sawston site.
I dont have any concerns over Northwest. LP does what she is best at and that is taking care of herself and LG and Im here for the ride up.
If what BSB is asserting is indeed true, then Advent is obviously handling the request for certification (not Northwest),
Again, even your own quoted citation indicates that it is the "manufacturing and distribution sites"
Advent Bioservices began activity as a cell therapy contract development & manufacturing organization in 2016 and is in the process of building a state-of-the-art multiproduct GMP production facility outside Sawston in Cambridgeshire, which will allow the scale up of current commercial production and the provision of contract manufacturing services to meet the growing demand for such services in the UK. Methods, Results & Conclusion
Advent Bioservices is currently in the process of applying for licencing and accreditation from UK authorities including the HTA, MHRA and HFEA for the Sawston site.
But carrying out your own analogy further, it is Northwest that owns the plane, not the pilot. Northwest has hired a certified pilot to fly the aircraft certified plane that has been determined to be in airworthy condition.
which will allow the scale up of current commercial production and the provision of contract manufacturing services
On May 7, the application package was submitted to the MHRA requesting the certification of the Sawston facility to produce Good Manufacturing Practice (GMP) clinical grade medical products for patients
Advent Bioservices began activity as a cell therapy contract development & manufacturing organization in 2016 and is in the process of building a state-of-the-art multiproduct GMP production facility outside Sawston in Cambridgeshire, which will allow the scale up of current commercial production and the provision of contract manufacturing services to meet the growing demand for such services in the UK.
Methods, Results & Conclusion
Advent Bioservices is currently in the process of applying for licencing and accreditation from UK authorities including the HTA, MHRA and HFEA for the Sawston site.
thanks Jack for your support.
Yes I agree
This board has become toxic for those bringing across simple facts from authorities, facts that many here dont want to hear
I remember 3,5 years ago I posted an email that PEI Germany send me. From that email, it was clear that everything was going to take way and way much longer. Like now I then got name called, I was dumb and stupid and inept, just for bringing across that what an RA, like the MHRA now, has said.
Many here can't deal with reality.
If Advent were to leave and take their people elsewhere, could they take the Sawston certification elsewhere? No.
(GMP) and/or good distribution practice (GDP) include:
manufacturer licence holders
wholesale dealer licence holders
blood establishment authorisation holders
non-UK sites employed by UK MA holders
MHRA carries out inspections to check if manufacturing and distribution sites comply with GMP or GDP. You will be inspected when you apply for a manufacturer or wholesaler dealer licence and then periodically based on risk assessments. Overseas manufacturing sites are also inspected.
If an organisation manufactures or distributes both human and veterinary medicines, MHRA may carry out an inspection of both areas on behalf of the Veterinary Medicines Directorate.
And finally, have you thought about what happens to Advent’s staff as Northwest transitions to the Flaskworks equipment?
its a simple fact denied by some here I have no idea why simple facts are so difficult for some to accept. I personally dont care, I bought NWBO shares knowing fully well that LP is a self-dealing egoist.
If NWBO would be a CDMO then NWBO would be worth around 500 million more than its now big deal. NWBO holds IP which is worth way more than a CDMO ever can be worth.
Advent hiring great qualified people? Good for LP what has that got todo with Northwest? No idea.
Sojo you are the best!!!
The CERTIFICATE OF GMP COMPLIANCE will be owned by Northwest Biotherapeutics.
LG's dogs had to be double-checked in Bern Switzerland so you know private yet, 4000$ a night hotel in the alps you know the lights on kinda stuff... lol
they are burning at a rate of 100 million shares every 6 months so thats like $50 million per year ex loans
time flies
https://citywire.co.uk/funds-insider/news/woodfords-new-biotech-could-be-the-next-amgen/a785925 26 Nov, 2014
The boss of Northwest Biotherapeutics (NWBO.O), the US cancer drug specialist that is the latest investment by fund manager Neil Woodford, believes the firm could become the next biotech colossus if medical trials of its products go well.
The Nasdaq-listed company is valued around $300 million (£200 million) today but chief executive Linda Powers said if phase III trials for its main tumour treatment were successful next year the firm could eventually match biotech pioneers Genentech and Amgen.
Genentech was sold to Roche (ROG.VX) of Switzerland for $48 billion (£30 billion) in 2009 and Amgen (AMGN.O) is the world's largest independent biotech company valued at $123 billion (£78 billion) on Nasdaq, the US technology stock exchange.
Many successful biotech companies end up being snapped up by big drugs companies hungry for new products but Powers insisted she wanted to ‘go big or go home’.
‘Our intention is to stay independent and not to be bought by another company,’ she said.
5:19 where you are? Why aren’t you asleep?
Barclays bank does not make DCVax or any biological products and is not qualified to do so.
You go to such an extent to make yourself seem right that you suggest NWBO is lying on their PR releases
I certainly hope he`s correct .
Me too. I cant imagine NWBO not PRing this!